SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Eagle Pharmaceuticals Q1 EPS $0.84 Beats $0.57 Estimate, Sales $46.020M Miss $51.100M Estimate

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.840 per share which beat the analyst consensus estimate of $0.570 by 47.37 percent. This is a 16.83 percent decrease over earnings of $1.010 per share

Benzinga · 05/11/2020 11:04

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.840 per share which beat the analyst consensus estimate of $0.570 by 47.37 percent. This is a 16.83 percent decrease over earnings of $1.010 per share from the same period last year. The company reported quarterly sales of $46.020 million which missed the analyst consensus estimate of $51.100 million by 9.94 percent. This is a 7.56 percent decrease over sales of $49.785 million the same period last year.